Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0820-2025

Citric Complete - Dry Citric Acid Concentrate Recall

Citric Complete - Dry Citric Acid Concentrate Model Number: DCA+225-25

FDA recall Class II

Ongoing

FDA lists this Class II recall for Citric Complete - Dry Citric Acid Concentrate. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0820-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 22, 2024
FDA report date
Jan 15, 2025
Quantity in commerce
2,810 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Citric Complete - Dry Citric Acid Concentrate Model Number: DCA+225-25

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Model Number: DCA+225-25. Lot Numbers: NDC4F001, NDC4G006, NDC4H009, NDC4H010.

View the original FDA recall notice

Why was this product recalled?

The outer case is mislabeled as 3.0 K, 2.0 Ca instead of 2.0 K, 3.0 Ca.

What actions did Nipro Renal Soultions USA, Corporation take?

Nipro notified their distributor on 11/22/2024 via email. Direct customers were notified via email on 11/25/2024. The firm sent a "Medical Device Recall" letter dated 11/11/2024 to its customers. The letter instructed customers to place any affected units in inventory on hold and return them immediately. They were also instructed to complete the quantity in stock column on the attached response form and return to [email protected] for processing. Nipro Partner Solutions team will coordinate the return of all recalled products from your facility back to Nipro. If you have any questions, contact Director QA/RA at 717-938-8391.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology